Short Ideas

[CHM_760]

I've been a holder since under $2 last summer. I'm also waiting for P3 Brilacidin to get a go-ahead before adding substantially to my holdings, although I did snatch a few shares on the dip last week.

I'm also excited for the Brilacidin-OM trial for oral mucositis to start. That indication is for an un-met need and the trial site has been announced as being MD Anderson, which may bring some much-needed credibility to the company.

I remember back in the gloomiest COR days your saying that you were no longer going to do cash investments in biotech, just "on paper" investments. Is that still the case?